A report on the global market human growth hormone (hGH) has been added to the briskly accumulating portfolio of ResearchMoz.us. Titled, “Global Human Growth Hormone (hGH) Market: Industry Analysis & Outlook (2018-2022),” the study analyzes the development of this market. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The exhaustive study includes the future reports and future prospects of the industry, including market share and size on account of risk factors, along with updates current trends and opportunities. This report forecasts revenue growth at global, regional, & country levels and provides an reports on industry trends in each of the sub-segments from 2018 to 2022.
Growth hormone (GH)/ Human Growth hormone (hGH) is a type of peptide hormone produced by the body which is responsible for stimulating cell reproduction, growth and regeneration amongst humans. Within the anterior of pituitary glands, lateral wings are present the somatotropic cells which synthesize, store, and secrete the GH, a 191-amino acid in single chain polypeptide. It is responsible for keeping a check over the normal human growth and development especially amongst the teenagers and children. Apart from stimulating cell growth and maintaining muscle mass, hGH also prompts the liver to produce IGF-l which in turn regulates the metabolic functioning of muscles, tissues and osteocytes.
The deficiency of growth hormone is termed as Growth Hormone Deficiency (GHD), which is a medical condition affecting both children and adults. Amongst children, GHD could be associated with congenital conditions, like marred pituitary development and other genetic abnormalities. On the other hand, GHD amongst adults is supposedly linked with pituitary tumors and it usually has non-specific symptoms, like weight gain, reduced energy levels, disturbed sleep, and emotional sickness. Depending upon the indications targeted, the hGH market can be segmented into two broad categories; Pediatric GHD and others. Others segment include adult GHD, PWS, ISS and other GH related abnormalities.
For Sample Copy, click here: https://www.marketresearchreports.biz/sample/sample/1644837
The global hGH market is driven by development and entry of long-acting drugs, rising cases of cancer and HIV/AIDS, higher incidence of GHD and other related diseases, rising healthcare expenditure and increasing purchasing power. However, this market growth is challenged by high cost of drugs, off-label uses of hGH drugs and side effects related to rhGH.
Investment for the development of effective & long-acting products with lesser adverse effects and improving geographic penetration through partnerships and collaborations are the key strategies adopted by the companies to increase their market share. For instance, in December 2014, Pfizer entered into an agreement with OPKO for development and commercialization of human growth hormone hGH-CTP for treatments in children and adults.
The hGH market is consolidated in nature. Presence of large patient pool in the Asia Pacific region and increasing awareness about the effectivity of the GH is anticipated to boost the market in coming years. Major players operating in the market are Novartis Ag, Pfizer Inc., Eli Lilly and Company, and Novo Nordisk A/S have being profiled along with their key financials and strategies for growth.
To order report Call Toll Free: 866-997-4948 or send an email on firstname.lastname@example.org